Adel El Abbassi, MD
Pulmonary Disease · Abingdon, VANPI 1437346301
Payments from drug & device makers
Across 605 payments — averaging $41.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- AstraZeneca$3K
- Pinnacle Biologics, Inc$2K
- GSK$2K
- Covidien LP$1K
- Olympus Corporation Of The Americas$1K
- plus $7K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $7,123 |
| AstraZeneca | 114 | $3,345 |
| Pinnacle Biologics, Inc | 11 | $2,334 |
| GSK | 141 | $2,194 |
| Covidien LP | 9 | $1,467 |
| Olympus Corporation Of The Americas | 10 | $1,124 |
| Regeneron Healthcare Solutions, Inc. | 32 | $929 |
| Actelion Pharmaceuticals US, Inc. | 40 | $906 |
| Boehringer Ingelheim | 29 | $503 |
| Grifols USA, LLC | 21 | $454 |
| Mallinckrodt Hospital Products Inc. | 20 | $452 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $403 |
| Sanofi | 16 | $389 |
| Johnson & Johnson(2 entities) | 5 | $326 |
| Amgen | 20 | $321 |
| United Therapeutics Corporation | 9 | $266 |
| Merck | 10 | $251 |
| Insmed, Inc. | 11 | $247 |
| CSA Medical, Inc | 1 | $214 |
| Mylan Specialty L.p. | 12 | $172 |
| Jazz Pharmaceuticals Inc. | 5 | $171 |
| Mallinckrodt Enterprises LLC | 6 | $161 |
| Baxter Healthcare | 7 | $156 |
| La Jolla Pharmaceutical Company | 6 | $149 |
| Genentech USA, Inc. | 7 | $114 |
| AbbVie | 1 | $91 |
| Pulmonx Corporation | 3 | $88 |
| Circassia Inc. | 5 | $67 |
| Inogen, Inc. | 3 | $63 |
| Novartis | 3 | $58 |
| Verona Pharma, Inc. | 3 | $57 |
| Pfizer | 3 | $47 |
| Electromed, Inc. | 2 | $43 |
| Viatris Specialty LLC | 2 | $41 |
| Philips North America LLC | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Resmed Corp | 1 | $21 |
| Medtronic | 1 | $21 |
| Olympus America Inc. | 1 | $20 |
| Shionogi Inc | 1 | $19 |
| Harmony Biosciences LLC | 1 | $16 |
How this compares
$24,886 in reported general payments places this provider in the 80th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Abingdon
- Steven NathanFalls Church$2.5M
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Rabih HalabiFalls Church$604K
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
- Hannah MannemCharlottesville$326K
- Ray ShepherdRichmond$303K
- Eric LibreAnnandale$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.